top of page

NCI-H1703 Xenograft Model

Rincon Bio offers efficacy studies using the NCI-H1703 Xenograft Model at our U.S.-based facilities, with direct access to the scientists conducting your study.

Model Type:
Xenograft
Organ:
Lung
Derivation:
Primary stage I lung cancer of a 54yo male smoker
Mutations:
CDKN2A, TP53
NCI60:
No
Weeks from stratification to termination (average):
3

NCI-H1703 Growth Curve

(Representative of studies performed at Rincon Bio)

Representative tumor growth curve for the NCI-H1703 xenograft model from studies performed at Rincon Bio.

For more information on this model, including available control data, please Contact Us, or request a Quote below

All Xenograft Models

All Syngeneic Models

bottom of page